chr11-66070551-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_018026.4(PACS1):c.65G>A(p.Gly22Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000283 in 1,413,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018026.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PACS1 | NM_018026.4 | c.65G>A | p.Gly22Glu | missense_variant | 1/24 | ENST00000320580.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PACS1 | ENST00000320580.9 | c.65G>A | p.Gly22Glu | missense_variant | 1/24 | 1 | NM_018026.4 | P2 | |
PACS1 | ENST00000527224.1 | n.189G>A | non_coding_transcript_exon_variant | 1/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151708Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.92e-7 AC: 1AN: 1262102Hom.: 0 Cov.: 31 AF XY: 0.00000161 AC XY: 1AN XY: 620514
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151708Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74088
ClinVar
Submissions by phenotype
Schuurs-Hoeijmakers syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jan 22, 2021 | The c.65G>A (p.Gly22Glu) variant identified in the PACS1 gene substitutes a moderately conserved Glycine for Glutamic Acid at amino acid 22/964 (exon 1/24). This variant is found with low frequency in gnomAD (3 heterozygotes, 0 homozygotes; allele frequency: 1.98e-5) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms do not agree on the function of this variant, as it is predicted both Damaging (SIFT; score:0.00) and Benign (REVEL; 0.03099) to the function of the canonical transcript. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature. Given the lack of compelling evidence for its pathogenicity, the c.65G>A (p.Gly22Glu) variant identified in the PACS1 gene is reported as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at